335 related articles for article (PubMed ID: 36047812)
1. Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review.
Wang Y; Sun X
Ren Fail; 2022 Dec; 44(1):1501-1518. PubMed ID: 36047812
[TBL] [Abstract][Full Text] [Related]
2. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients.
Moore CL; Besarab A; Ajluni M; Soi V; Peterson EL; Johnson LE; Zervos MJ; Adams E; Yee J
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1232-9. PubMed ID: 24970874
[TBL] [Abstract][Full Text] [Related]
3. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis.
Sheng KX; Zhang P; Li JW; Cheng J; He YC; Böhlke M; Chen JH
Clin Microbiol Infect; 2020 May; 26(5):545-552. PubMed ID: 31857208
[TBL] [Abstract][Full Text] [Related]
5. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
[TBL] [Abstract][Full Text] [Related]
6. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
Trials; 2014 Nov; 15():449. PubMed ID: 25409678
[TBL] [Abstract][Full Text] [Related]
7. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials.
Mai H; Zhao Y; Salerno S; Li Y; Feng Y; Ma L; Fu P
Int Urol Nephrol; 2019 Jun; 51(6):1019-1033. PubMed ID: 31012037
[TBL] [Abstract][Full Text] [Related]
8. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
Yon CK; Low CL
Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
[TBL] [Abstract][Full Text] [Related]
9. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus.
Pittiruti M; Bertoglio S; Scoppettuolo G; Biffi R; Lamperti M; Dal Molin A; Panocchia N; Petrosillo N; Venditti M; Rigo C; DeLutio E
J Vasc Access; 2016 Nov; 17(6):453-464. PubMed ID: 27516141
[TBL] [Abstract][Full Text] [Related]
11. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
[TBL] [Abstract][Full Text] [Related]
13. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis.
Han X; Yang X; Huang B; Yuan L; Cao Y
Clin Nephrol; 2016 Jul; 86(7):1-8. PubMed ID: 27191662
[TBL] [Abstract][Full Text] [Related]
14. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.
Moran JE; Ash SR;
Semin Dial; 2008; 21(5):490-2. PubMed ID: 18764795
[TBL] [Abstract][Full Text] [Related]
15. The best solution down the line: an observational study on taurolidine- versus citrate-based lock solutions for central venous catheters in hemodialysis patients.
van Roeden S; van Oevelen M; Abrahams AC; Dekker FW; Rotmans JI; Meijvis SCA;
BMC Nephrol; 2021 Sep; 22(1):308. PubMed ID: 34517829
[TBL] [Abstract][Full Text] [Related]
16. Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis: A Randomized, Double-Blind, Active-Control, Phase 3 Study.
Agarwal AK; Roy-Chaudhury P; Mounts P; Hurlburt E; Pfaffle A; Poggio EC
Clin J Am Soc Nephrol; 2023 Nov; 18(11):1446-1455. PubMed ID: 37678222
[TBL] [Abstract][Full Text] [Related]
17. A 2% taurolidine catheter lock solution prevents catheter-related bloodstream infection (CRBSI) and catheter dysfunction in hemodialysis patients.
Neusser MA; Bobe I; Hammermeister A; Wittmann U
Br J Nurs; 2021 Jul; 30(14):S24-S32. PubMed ID: 34288746
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.
Hemmelgarn BR; Manns BJ; Soroka SD; Levin A; MacRae J; Tennankore K; Wilson JS; Weaver RG; Ravani P; Quinn RR; Tonelli M; Kiaii M; Mossop P; Scott-Douglas N
Clin J Am Soc Nephrol; 2018 Mar; 13(3):429-435. PubMed ID: 29335321
[TBL] [Abstract][Full Text] [Related]
19. Use of a gentamicin-citrate lock leads to lower catheter-related bloodstream infection rates and reduced cost of care in hemodialysis patients.
Hussein WF; Gomez N; Sun SJ; Yu J; Yang F; Ajuria M; Abra GE; Schiller B
Hemodial Int; 2021 Jan; 25(1):20-28. PubMed ID: 33006269
[TBL] [Abstract][Full Text] [Related]
20. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces.
Shanks RM; Sargent JL; Martinez RM; Graber ML; O'Toole GA
Nephrol Dial Transplant; 2006 Aug; 21(8):2247-55. PubMed ID: 16627606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
